Skip to main navigation
logo
Menu
  • About
    • Overview
    • History
    • Values
    • Management
    • Board of Directors
    • Diversity & Inclusion
    • Social Community Guidelines
  • Programs
    • Overview
    • Sickle Cell Disease
    •   – Voxelotor
    •   – Inclacumab
    • Presentations and Publications
  • Our Medicine
  • Patients & Physicians
    • GBT's Commitment
    •   – GBT Supported Conferences
    • Sickle Cell Disease Resources
    • Funding and Support
    • Expanded Access Policy
  • Investors

    Header menu

    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
    • E-mail Alerts
    • IR Contact
  • Media
  • Careers
  • Contact
youtube
twitter
linkedin

Investors

8-K

SEC Filing Details

Document Details

Form
8-K
Filing Date
Nov 26, 2019
Document Date
Nov 25, 2019
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Global Blood Therapeutics, Inc.
Issuer
Global Blood Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL SCHEMA FILE
EX-101.DEF - XBRL DEFINITION FILE
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT

Investor Relations

  • Company Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
  • Investor FAQs
  • E-mail Alerts
  • IR Contact

Shareholder Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • IR Contact
© Global Blood Therapeutics Inc. Home | Privacy Policy